DMIIR

The current price of Drugs Made In America Acquisition II Corp. Ordinary Shares (DMIIR) is 0.0850. Over the past 24 hours, the stock has changed by -1.25%. Follow the DMIIR chart for real-time price dynamics.

Drugs Made In America Acquisition II Corp. Ordinary Shares trades under the ticker DMIIR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

DMIIR has changed by +17.89% over the last week, -5.56% over the last month, and -46.88% over the last year. Review the chart to see whether the current move is part of a broader trend.

Drugs Made In America Acquisition II Corp. Ordinary Shares currently has a market capitalization of 645.92 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Last quarter, Drugs Made In America Acquisition II Corp. Ordinary Shares reported earnings of 0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

Drugs Made In America Acquisition II Corp. Ordinary Shares reported net income of 4.4 M for the last quarter. The previous quarter showed 4.34 M, which means net income changed by +1.35%.

As of the latest available data, Drugs Made In America Acquisition II Corp. Ordinary Shares has 2 employees. Workforce size can provide additional context about the company's scale and operations.

You can buy Drugs Made In America Acquisition II Corp. Ordinary Shares (DMIIR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Investing in Drugs Made In America Acquisition II Corp. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DMIIR chart and related analysis on metatrader.com as part of your research.